ロード中...

5‐aminolaevulinic acid/photo‐dynamic therapy and gefitinib in non‐small cell lung cancer cell lines: a potential strategy to improve gefitinib therapeutic efficacy

OBJECTIVES: Often, non‐small cell lung cancers (NSCLC) respond only poorly to the tyrosine kinase inhibitor (TKI) gefitinib, which targets the epidermal growth factor receptor (EGFR), these poor responders EGFRs lacking activating mutations. In this study, we have attempted to improve TKI response o...

詳細記述

保存先:
書誌詳細
出版年:Cell Prolif
主要な著者: Postiglione, I., Chiaviello, A., Aloj, S. M., Palumbo, G.
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2013
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6622218/
https://ncbi.nlm.nih.gov/pubmed/23869760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12040
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!